Deutsche Märkte geschlossen

Paradigm Biopharmaceuticals Limited (PAR.AX)

ASX - ASX Verzögerter Preis. Währung in AUD
Zur Watchlist hinzufügen
0,2350-0,0100 (-4,08%)
Börsenschluss: 04:10PM AEST

Insider-Transaktionen

Währung in AUD
Insider-Käufe (letzte 6 Monate)AktienTrans
Käufe00
VerkaufN/A0
Gekaufte Nettoaktien (verkauft)00
Insideraktien mit Beteiligung (gesamt)45,79MN/A
% Gekaufte Nettoaktien (verkauft)N/AN/A
Institutionelle Käufe (netto) der letzten QuartaleAktien
Gekaufte Nettoaktien (verkauft)N/A
% Schwankung in institutioneller AktienbeteiligungN/A

Gemeldete Insider-Transaktionen – Letzte zwei Jahre

InsiderTransaktionTypWertDatumAktien

Rennie (Paul)
Managing Director

Other at price 0.88 per share.Direkt117.04914. Sept. 2022133.435

Rennie (Paul)
Managing Director

Other at price 0.88 per share.Direkt88.07914. Sept. 2022100.410

Rennie (Paul)
Managing Director

Purchase at price 0.76 per share.Direkt36.78908. März 202248.167

Skerrett (Donna M.D.)
Director (Executive)

Other at price 1.35 per share.Direkt506.58725. Jan. 2022375.000

Skerrett (Donna M.D.)
Director (Executive)

Other at price 2.22 per share.Direkt1.111.25019. Nov. 2020500.000

Fullerton (Christopher Maxwell)
Former

Direkt19. Nov. 20201.000.000

Rennie (Paul)
Managing Director

Other at price 2.22 per share.Direkt1.333.50019. Nov. 2020600.000

Gaffney (John)
Director (Non-Executive)

Purchase at price 1.54 per share.Direkt177.89211. Mai 2020115.695

Kaufman (Graeme Roy)
Non Executive Chairman

Purchase at price 1.50 per share.Direkt276.61808. Mai 2020184.216

Rennie (Paul)
Managing Director

Sale at price 1.50 per share.Direkt6.203.96208. Mai 20204.131.568

Rennie (Paul)
Managing Director

Purchase at price 1.08 per share.Direkt30.83113. März 202028.500

Fullerton (Christopher Maxwell)
Director (Non-Executive)

Purchase at price 2.06 per share.Direkt205.81913. Nov. 2019100.000

Rennie (Paul)
Managing Director

Other at price 2.02 per share.Direkt398.81407. Nov. 2019197.355

Rennie (Paul)
Managing Director

Purchase at price 0.98 per share.Direkt34.39828. Juni 201935.000

Fullerton (Christopher Maxwell)
Director (Non-Executive)

Direkt27. Juni 201910.000

Fullerton (Christopher Maxwell)
Director (Non-Executive)

Direkt13. Mai 2019104.500

Fullerton (Christopher Maxwell)
Director (Non-Executive)

Purchase at price 1.17 per share.Direkt22.81523. Apr. 201919.500

Fullerton (Christopher Maxwell)
Director (Non-Executive)

Purchase at price 0.84 per share.Direkt83.68004. März 2019100.000

Rennie (Paul)
Managing Director

Other at price 0.51 per share.Direkt394.72213. Dez. 2018780.392

Fullerton (Christopher Maxwell)
Director (Non-Executive)

Purchase at price 0.32 per share.Direkt11.53404. Mai 201836.000

Rennie (Paul)
Managing Director

Other at price 0.48 per share.Direkt100.65313. Nov. 2017210.001

Rennie (Paul)
Managing Director

Purchase at price 0.27 per share.Direkt76.09523. Juni 2017285.000

Fullerton (Christopher Maxwell)
Director (Non-Executive)

Other at price 0.34 per share.Direkt28.56808. Dez. 201682.855

Gaffney (John)
Director (Non-Executive)

Other at price 0.36 per share.Direkt11.18708. Dez. 201631.250

Kaufman (Graeme Roy)
Non Executive Chairman

Other at price 0.36 per share.Direkt11.18708. Dez. 201631.250

Rennie (Paul)
Managing Director

Other at price 0.33 per share.Direkt183.75508. Dez. 2016556.667

Gaffney (John)
Director (Non-Executive)

Purchase at price 0.38 per share.Direkt15.07609. Sept. 201640.000

Rennie (Paul)
Managing Director

Purchase at price 0.22 per share.Direkt74.49910. März 2016333.333

Gaffney (John)
Director (Non-Executive)

Purchase at price 0.22 per share.Direkt7.16809. Dez. 201532.000